Well with all of the negative press that is going on, I woke up to a good news story this morning, as the US company Moderna announced that within it’s second stage trials, its Covid19 vaccine had produced antibodies to the virus in all of its patients.
Whereas some companies are producing a treatment which aims to control the virus and aid recovery within individuals, Moderna are the main candidates for producing an actual preventative vaccine so this news, coming as far down the line as the testing process already is, is really encouraging!
As you may expect, the investment markets have responded well to the news and are moving upwards, not only in the US but also throughout the UK and other countries. This is in spite of the wider doom and gloom which still exists out there.
Issues may still surround the availability and licensing of any vaccine, should the trials be successful, but news such as this can only be a good thing, with the concerns of a second wave of the virus always looming large.
I have added a link below, which shows the movement in % terms of the various investment classes over recent months and as illustrated, it has been a quiet month overall, apart from the technology company shares sector, which has been racing ahead, as a new era dawns for greater technological processes for businesses with sights set on more remote working practices with staff and customers.
In summary, a good news story which would certainly go a long way towards solving the ongoing threat of this virus, but there is still a lot of work to do in terms of balancing the books and I am sure we will see more about this in the months to come.
https://www.trustnet.com/fund/sectors/performance?universe=O